Transtech Pharma is a privately held, clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of small molecule and protein therapeutics. The company develops drugs for the treatment of diabetes, cancer, obesity, cardiovascular diseases and central nervous system disorders. Transtech Pharma utilizes the Translational Technology, which translates the functional modulation of human proteins into medicines. The company also develops TTPredict, which provides modeling and statistical and analysis algorithm tools for scientists and collaborators. Transtech Pharma s products include PTP1B inhibitors, GLP1R agonists and glucokinase activators. In addition, the company s other drug discovery technologies include TTPSpace and TTPScreen. It offers a range of research and development services.